When Pfizer first introduced Chantix in 2006, it was hailed as a revolutionary smoking cessation drug that could help smokers quit tobacco within 12 weeks. It was not long before the drug made it to Canada and Europe under the name Champix. However, the success of the drug, along with its safety record, has been much debated ever since. New data from Canada suggests Champix is far from being the safest cigarette alternative available.

A January 10th (2015) report from the Vancouver Sun claims that Champix is at least partially responsible for as many as 40 deaths in Canada since 2007. Among those 40 deaths, 33 were classified as suicides. Approximately 1,300 cases involving suicidal thoughts, anger, aggressiveness and depression have also been linked to the drug as well.

The release of this new data from Canada is sure to be unwelcome news for Pfizer. Despite denying claims that its flagship smoking cessation drug is dangerous, evidence to the contrary is steadily mounting. In addition, Pfizer cannot deny that since 2007, the US's Food and Drug Administration (FDA) has required their drug to carry a 'black box warning' in the USA.

A black box warning is the strongest warning the FDA can insist upon for American pharmaceutical products. Such a warning demonstrates the drug carries an unusually high risk of serious or life-threatening side effects. We are not pharmaceutical experts, but it seems to us that any drug requiring a black box warning cannot possibly be one of the safest cigarette alternatives.

A Better Choice...

It should be noted that Pfizer's own clinical trials showed the success rate of Champix to be about 23% as compared to 10% for the Placebo group. This means that less than 1 in 4 smokers who take the drug to stop smoking can expect to be successful at the one-year mark. The risks associated with the drug suggest need to be carefully considered if you are concerned about the known potential side effects.

From our perspective, there is a better choice for smokers anyway: electronic cigarettes. We cannot and will not say whether making the switch to e-cigs will help you stop smoking or not. However, when you compare the warnings that come with taking Champix, to any of the possible concerns related to e-cigarettes, there is no comparison.

Electronic cigarettes first came out of China in 2004. They made it to European markets around 2007. This means both e-cigarettes and Champix have been used in Europe for roughly the same amount of time. Yet there have been no reports of any psychotic episodes relating to the use of vaping products. Not a one.

E-cigarettes work well as a tobacco substitute because they address most of the needs of the smoker without burning tobacco. Moreover, where there is no burning tobacco, there can be no toxic cigarette smoke.

We can say with confidence that Champix is far from being the safest cigarette alternative on the market. If you are looking to replace or reduce your tobacco consumption, we'd suggest any e-cigarette from VAPESTICK to be a sound choice.